Isabelle Vanden Bempt

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Oskar Marín-Béjar, Aljosja Rogiers, Michael Dewaele et al. · Cancer Cell · 2021 · 154 citations · Full text

Life Sciences, Genetics, Oncology +14

Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing

Isabelle Vanden Bempt, Peter Van Loo, M. Drijkoningen et al. · Journal of Clinical Oncology · 2008 · 151 citations · Full text

Medicine, Oncology, Pathology +16

The E2F-Regulated Gene <i>Chk1</i> Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas

Lieve Verlinden, Isabelle Vanden Bempt, Guy Eelen et al. · Cancer Research · 2007 · 142 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive

Ben Van Calster, Isabelle Vanden Bempt, M. Drijkoningen et al. · Breast Cancer Research and Treatment · 2008 · 91 citations

Medicine, Oncology, Breast Oncology +15

Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies

Liesbeth Lenaerts, Nathalie Brison, Charlotte Maggen et al. · EClinicalMedicine · 2021 · 82 citations · Full text

Medicine, Genetics, Molecular Genetics +17